Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2016, Article ID 3865454, 8 pages
http://dx.doi.org/10.1155/2016/3865454
Research Article

Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester

1Department of Obstetrics & Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Obstetrics & Gynecology, Puyang Oilfield General Hospital, Puyang, China
3Department of Gynecology, Guangdong No. 2 Provincial People’s Hospital, Guangzhou, China

Received 22 April 2016; Revised 4 August 2016; Accepted 15 August 2016

Academic Editor: Shi-Wen Jiang

Copyright © 2016 Hongwei Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Noctor, C. Crowe, L. A. Carmody et al., “ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria,” Acta Diabetologica, vol. 52, no. 1, pp. 153–160, 2015. View at Publisher · View at Google Scholar
  2. E. P. Gunderson, V. Chiang, M. J. Pletcher et al., “History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study,” Journal of the American Heart Association, vol. 3, no. 2, Article ID e000490, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. B. E. Metzger, L. P. Lowe, A. R. Dyer et al., “Hyperglycemia and adverse pregnancy outcomes,” The New England Journal of Medicine, vol. 358, no. 19, pp. 1991–2002, 2008. View at Publisher · View at Google Scholar
  4. P. Damm, “Future risk of diabetes in mother and child after gestational diabetes mellitus,” International Journal of Gynecology and Obstetrics, vol. 104, supplement 1, pp. S25–S26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Nilsson, A. Carlsson, and M. Landin-Olsson, “Increased risk for overweight among Swedish children born to mothers with gestational diabetes mellitus,” Pediatric Diabetes, vol. 15, no. 1, pp. 57–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Z. Pan, L. Zhang, M. Guo et al., “The oxidative stress status in diabetes mellitus and diabetic nephropathy,” Acta Diabetologica, vol. 47, supplement 1, pp. 71–76, 2010. View at Publisher · View at Google Scholar
  7. X. Cheng, S. J. Chapple, B. Patel et al., “Gestational diabetes mellitus impairs Nrf2-mediated adaptive antioxidant defenses and redox signaling in fetal endothelial cells in utero,” Diabetes, vol. 62, no. 12, pp. 4088–4097, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Gelisgen, H. Genc, R. Kayali et al., “Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 404–409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. E. Boyle, S. A. Newsom, R. C. Janssen, M. Lappas, and J. E. Friedman, “Skeletal muscle MnSOD, mitochondrial complex II, and SIRT3 enzyme activities are decreased in maternal obesity during human pregnancy and gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 10, pp. E1601–E1609, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. T. Coughlan, M. Permezel, H. M. Georgiou, and G. E. Rice, “Repression of oxidant-induced nuclear factor-κB activity mediates placental cytokine responses in gestational diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 7, pp. 3585–3594, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. John, R. Ramasamy, G. Al Naqeeb, A. H. Dhiab Al-Nuaimi, and A. Adam, “Enhanced CD4+CD25+ regulatory T cells with splenic proliferation and protection against oxidative stress by nicotinamide in gestational diabetes,” Current Medicinal Chemistry, In press.
  12. T. Reinheckel, B. Nedelev, J. Prause et al., “Occurrence of oxidatively modified proteins: an early event in experimental acute pancreatitis,” Free Radical Biology and Medicine, vol. 24, no. 3, pp. 393–400, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. K. B. Pandey, N. Mishra, and S. I. Rizvi, “Protein oxidation biomarkers in plasma of type 2 diabetic patients,” Clinical Biochemistry, vol. 43, no. 4-5, pp. 508–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Tabak, R. Gelisgen, H. Erman et al., “Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus,” Clinical and Investigative Medicine, vol. 34, no. 3, pp. E163–E171, 2011. View at Google Scholar · View at Scopus
  15. G. Baskol, K. Gumus, A. Oner, H. Arda, and S. Karakucuk, “The role of advanced oxidation protein products and total thiols in diabetic retinopathy,” European Journal of Ophthalmology, vol. 18, no. 5, pp. 792–798, 2008. View at Google Scholar · View at Scopus
  16. M. E. Hartnett, R. D. Stratton, R. W. Browne, B. A. Rosner, R. J. Lanham, and D. Armstrong, “Serum markers of oxidative stress and severity of diabetic retinopathy,” Diabetes Care, vol. 23, no. 2, pp. 234–240, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Ziegler, C. G. H. Sohr, and J. Nourooz-Zadeh, “Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy,” Diabetes Care, vol. 27, no. 9, pp. 2178–2183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. B. E. Metzger, S. G. Gabbe, B. Persson et al., “International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy,” Diabetes Care, vol. 33, no. 3, pp. 676–682, 2010. View at Publisher · View at Google Scholar
  19. V. Witko-Sarsat, M. Friedlander, C. Capeillère-Blandin et al., “Advanced oxidation protein products as a novel marker of oxidative stress in uremia,” Kidney International, vol. 49, no. 5, pp. 1304–1313, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Vazzana, A. Ganci, A. B. Cefalù et al., “Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype,” The Journal of the American Heart Association, vol. 2, no. 2, Article ID e000063, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Flores, S. Rodela, J. Abian, J. Clària, and E. Esmatjes, “F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control,” Metabolism, vol. 53, no. 9, pp. 1118–1120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. L. Răchişan, A. Hruşcă, S. Căinap et al., “The activity of 8-iso-prostaglandin F2α as an oxidative stress marker in vivo in paediatric patients with type 1 diabetes mellitus and associated autoimmunities,” Clinical Laboratory, vol. 60, no. 2, pp. 253–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. De Cristofaro, B. Rocca, E. Vitacolonna et al., “Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus,” Journal of Thrombosis and Haemostasis, vol. 1, no. 2, pp. 250–256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Cederberg, S. Basu, and U. J. Eriksson, “Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy,” Diabetologia, vol. 44, no. 6, pp. 766–774, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lappas, M. Permezel, and G. E. Rice, “Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5627–5633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. T. Coughlan, P. P. Vervaart, M. Permezel, H. M. Georgiou, and G. E. Rice, “Altered placental oxidative stress status in gestational diabetes mellitus,” Placenta, vol. 25, no. 1, pp. 78–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Kaneda, J. Taguchi, K. Ogasawara, T. Aizawa, and M. Ohno, “Increased level of advanced oxidation protein products in patients with coronary artery disease,” Atherosclerosis, vol. 162, no. 1, pp. 221–225, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Piwowar, M. Knapik-Kordecka, and M. Warwas, “AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 77, no. 2, pp. 188–192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Gradinaru, C. Borsa, C. Ionescu, and D. Margina, “Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes,” Journal of Proteomics, vol. 92, pp. 313–322, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Liang, J. Wang, C. Xie et al., “Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria,” Journal of Diabetes, vol. 6, no. 5, pp. 417–426, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. Ö. Karacay, A. Sepici-Dincel, D. Karcaaltincaba et al., “A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation,” Diabetes Research and Clinical Practice, vol. 89, no. 3, pp. 231–238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Çakatay, “Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control,” Diabetes and Metabolism, vol. 31, no. 6, pp. 551–557, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. K. Patra, K. Singh, and R. Singh, “Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 7, no. 2, pp. 108–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Sozer, S. Himmetoglu, G. G. Korkmaz et al., “Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus,” Minerva Medica, vol. 105, no. 3, pp. 237–244, 2014. View at Google Scholar · View at Scopus
  35. H. Camuzcuoglu, H. Toy, H. Cakir, H. Celik, and O. Erel, “Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus,” Journal of Women's Health, vol. 18, no. 9, pp. 1435–1439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Agnani, O. Camacho-Vanegas, C. Camacho et al., “Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression,” Journal of Ovarian Research, vol. 4, no. 1, article 18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D.-F. Peng, T.-L. Hu, B. G. Schneider, Z. Chen, Z.-K. Xu, and W. El-Rifai, “Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas,” PLoS ONE, vol. 7, no. 10, Article ID e46214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. B. G. Baez-Duarte, I. Zamora-Ginez, F. Mendoza-Carrera et al., “Serum levels of glutathione peroxidase 3 in overweight and obese subjects from central Mexico,” Archives of Medical Research, vol. 43, no. 7, pp. 541–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Iwata, T. Nishinaka, K. Matsuno, and C. Yabe-Nishimura, “Increased gene expression of glutathione peroxidase-3 in diabetic mouse heart,” Biological and Pharmaceutical Bulletin, vol. 29, no. 5, pp. 1042–1045, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Lappas, U. Hiden, G. Desoye, J. Froehlich, S. H.-D. Mouzon, and A. Jawerbaum, “The role of oxidative stress in the pathophysiology of gestational diabetes mellitus,” Antioxidants & Redox Signaling, vol. 15, no. 12, pp. 3061–3100, 2011. View at Publisher · View at Google Scholar · View at Scopus